Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy - 25 year follow-up of a randomised trial from the South Sweden Breast Cancer GroupKILLANDER, Fredrika; ANDERSON, Harald; KJELLEN, Elisabeth et al.European journal of cancer (1990). 2014, Vol 50, Num 13, pp 2201-2210, issn 0959-8049, 10 p.Article

Recombinant erythropoietin β enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical traumaKJELLEN, Elisabeth; SASAKI, Yutaka; KJELLSTRÖM, Johan et al.Acta oto-laryngologica. 2006, Vol 126, Num 5, pp 545-547, issn 0001-6489, 3 p.Article

FDG-PET in cervical cancer : staging, re-staging and follow-upBJURBERG, Maria; KJELLEN, Elisabeth; OHLSSON, Tomas et al.Acta obstetricia et gynecologica Scandinavica. 2007, Vol 86, Num 11, pp 1385-1391, issn 0001-6349, 7 p.Article

A systematic overview of radiation therapy effects in non-small cell lung cancerSIRZEN, Florin; KJELLEN, Elisabeth; SÖRENSON, Sverre et al.Acta oncologica (Stockholm). 2003, Vol 42, Num 5-6, pp 493-515, issn 0284-186X, 23 p.Article

Interactions between chemotherapy, endocrine therapy and radiationGLIMELIUS, Bengt; NORDENSKJÖLD, Bo; KJELLEN, Elisabeth et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 7-8, pp 635-638, issn 0284-186X, 4 p.Article

DNA ploidy, S-phase fraction and associations with 2-¹⁸F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinomaBRUN, Eva; TENNVALL, Jan; BALDETORP, Bo et al.Acta oto-laryngologica. 2004, Vol 124, Num 6, pp 712-719, issn 0001-6489, 8 p.Article

Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenograftsYAMATODANI, Takashi; HOLMQVIST, B. O; KJELLEN, Elisabeth et al.Acta oto-laryngologica. 2012, Vol 132, Num 12, pp 1324-1333, issn 0001-6489, 10 p.Article

2 -Deoxy -2 -[¹⁸F]fluoro -D -glucose uptake and correlation to intratumoral heterogeneityHENRIKSSON, Eva; KJELLEN, Elisabeth; WAHLBERG, Peter et al.Anticancer research. 2007, Vol 27, Num 4B, pp 2155-2159, issn 0250-7005, 5 p.Article

Medical imaging for improved tumour characterization, delineation and treatment verificationFORSSELL-ARONSSON, Eva; KJELLEN, Elisabeth; MATTSSON, Sören et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 7-8, pp 604-614, issn 0284-186X, 11 p.Article

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell linesYAMATODANI, Takashi; EKBLAD, Lars; KJELLEN, Elisabeth et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 3, pp 395-402, issn 0171-5216, 8 p.Article

Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell linesOSHIMA, Goro; WENNERBERG, Johan; YAMATODANI, Takashi et al.Journal of cancer research and clinical oncology. 2012, Vol 138, Num 3, pp 491-499, issn 0171-5216, 9 p.Article

The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependentSASAKI, Yutaka; KJELLEN, Elisabeth; EKBLAD, Lars et al.Oral oncology (1997). 2012, Vol 48, Num 1, pp 61-66, issn 1368-8375, 6 p.Article

Research and development of radiation therapy in clinical routinesZACKRISSON, Björn; MATTSSON, Sören; KJELLEN, Elisabeth et al.Acta oncologica (Stockholm). 2003, Vol 42, Num 2, pp 115-122, issn 0284-186X, 8 p.Conference Paper

Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer : The CORGI-L studyGUNNLAUGSSON, Adalsteinn; ANDERSON, Harald; JOHNSSON, Anders et al.European journal of cancer (1990). 2009, Vol 45, Num 5, pp 807-813, issn 0959-8049, 7 p.Article

Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrierJOHANNSSON, Oskar T; STAFF, Synnöve; BALDETORP, Bo et al.Laboratory investigation. 2003, Vol 83, Num 3, pp 387-396, issn 0023-6837, 10 p.Article

Sensitizing and protective substances in radiation therapy and predictive assaysZACKRISSON, Björn; KJELLEN, Elisabeth; GLIMELIUS, Bengt et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 7-8, pp 615-622, issn 0284-186X, 8 p.Article

Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)MAGNUSSON, Marie; HÖGLUND, Peter; JOHANSSON, Karin et al.European journal of cancer (1990). 2009, Vol 45, Num 14, pp 2488-2495, issn 0959-8049, 8 p.Article

FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinomaBRUN, Eva; KJELLEN, Elisabeth; TENNVALL, Jan et al.Head & neck. 2002, Vol 24, Num 2, pp 127-135, issn 1043-3074Article

Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomasBRUN, Eva; ZÄTTERSTRÖM, Ulf; KJELLEN, Elisabeth et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 4, pp 491-496, issn 0284-186XArticle

Swedish cancer society radiation therapy research investigationMATTSSON, Sören; BRAHME, Anders; STENERLÖW, Bo et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 7-8, pp 596-603, issn 0284-186X, 8 p.Article